Old Web
English
Sign In
Acemap
>
Paper
>
SAFETY OF SOLANEZUMAB IN PHASE 3 STUDIES IN INDIVIDUALS WITH MILD ALZHEIMER’S DISEASE DEMENTIA
SAFETY OF SOLANEZUMAB IN PHASE 3 STUDIES IN INDIVIDUALS WITH MILD ALZHEIMER’S DISEASE DEMENTIA
2017
Christopher Carlson
Greg Anglin
Michael G. Case
Brenda Crowe
Ann Marie Hake
Rashna Khanna
Ludmila Kryzhanovskaya
David Perahia
Gopalan Sethuraman
Roy Yaari
Sherie A. Dowsett
Eric Siemers
Keywords:
Psychiatry
Solanezumab
Psychology
Dementia
Disease
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]